Relative sensitivity of the Montgomery–Åsberg depression rating scale, the Hamilton depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials: a replication analysis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  International Clinical Psychopharmacology

• Publication date

  2004-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/00004850-200405000-00006PMID 15107658
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS).

  2003cited by this paper
• Relationships among measures of treatment outcome in depressed patients.

  2003cited by this paper
• Relative sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials

  2002influential reference
• A New Depression Scale Designed to be Sensitive to Change

  1979cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper

• Signal detection and placebo response in schizophrenia: parallels with depression.

  2025cites this paper
• Reward learning in obsessive-compulsive disorder: an attentional perspective

  2025cites this paper
• A sight for sore eyes? Attention allocation to obsession-provoking stimuli and stimuli reflecting compulsion completion

  2023cites this paper
• Essential data dimensions for prospective international data collection in older age bipolar disorder (OABD): Recommendations from the GAGE‐BD group

  2023cites this paper
• Interpreting patient reports of perceived change during treatment for depression: Findings from the Veterans Outcome Assessment survey.

  2022cites this paper
• Burden Experienced by Primary Caregivers of Children With Psychotic Disorders and at Clinical High Risk for Psychosis

  2022cites this paper
• Consistently Modest Antidepressant Effects in Clinical Trials: the Role of Regulatory Requirements.

  2021cites this paper
• The Work and Social Adjustment Scale, Youth and Parent Versions: Psychometric Evaluation of a Brief Measure of Functional Impairment in Young People

  2020cites this paper
• Post-Stroke Depressive Symptoms: Varying Responses to Escitalopram by Individual Symptoms and Lesion Location

  2020cites this paper
• The Work and Social Adjustment Scale, Youth and Parent Versions: Psychometric Evaluation of a Brief Measure of Functional Impairment in Young People

  2019cites this paper
• SIGMA-VB: Validity and reliability of the Brazilian Portuguese version of the Montgomery-Åsberg Depression Rating Scale using the Structured Interview Guide for the MADRS

  2019cites this paper
• Symptom structure of PTSD and co-morbid depressive symptoms – a network analysis of combat veteran patients

  2019cites this paper
• Improvement of postpartum depression and psychosis after electroconvulsive therapy: A population-based study with a matched comparison group.

  2018cites this paper
• Patient centric measures for a patient centric era: Agreement and convergent between ratings on The Patient Global Impression of Improvement (PGI-I) scale and the Clinical Global Impressions – Improvement (CGI-S) scale in bipolar and major depressive disorder

  2018cites this paper
• Everolimus induced mood changes in breast cancer patients: a case-control study

  2018cites this paper
• The conundrum of depression clinical trials: one size does not fit all

  2018cites this paper
• PsychotherapyPlus: augmentation of cognitive behavioral therapy (CBT) with prefrontal transcranial direct current stimulation (tDCS) in major depressive disorder—study design and methodology of a multicenter double-blind randomized placebo-controlled trial

  2017influential citation
• Transdiagnostic Clinical Global Impression Scoring for Routine Clinical Settings

  2017cites this paper
• Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: a multicentre, double-blind, randomised, placebo-controlled study.

  2017cites this paper
• Symptomatic Remission in Schizophrenia and its Relationship with Functional Outcome Measures in Indian Population.

  2017cites this paper
• Efficacy and safety of Xiangsha Liujunzi granules for functional dyspepsia: A multi-center randomized double-blind placebo-controlled clinical study

  2017cites this paper
• Diagnostic Validity and Factor Analysis of Montgomery-Asberg Depression Rating Scale in Parkinson Disease Population

  2016cites this paper
• Do Somatic Symptoms Predict the Severity of Depression? A Validation Study of the Korean Version of the Depression and Somatic Symptoms Scale

  2016cites this paper
• Spiegeln sich die Konstrukte Selbstermächtigung und Behandlungszufriedenheit im psychiatrischen Funktionsniveau wider

  2015cites this paper
• Effects of religiosity and spirituality on the treatment response in patients with depressive disorders.

  2015cites this paper
• Validation de la version française de l’échelle d’auto-évaluation de la dépression de Montgomery-Asberg MADRS-S

  2014cites this paper
• Rating Scales for Measurement-Based Clinical Practice of Depression

  2012cites this paper
• Neurobehavioral Effects of Interferon-α in Patients with Hepatitis-C: Symptom Dimensions and Responsiveness to Paroxetine

  2012cites this paper
• Depression symptom ratings in geriatric patients with bipolar mania

  2011cites this paper
• Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in hepatitis C: a 12-week, randomized, double-blind, placebo-controlled trial.

  2011cites this paper
• Citalopram for major depressive disorder in adults: a systematic review and meta-analysis of published placebo-controlled trials

  2011cites this paper
• Major Depresif Bozuklukta Tedavi Hedefleri ve Tedavinin İzlenmesi

  2011cites this paper
• Design Archetypes for Phase 2 Clinical Trials in Central Nervous System Disorders

  2010cites this paper
• Affective processing in major depressive disorder : neuroanatomical correlates of state and trait abnormailities.

  2010cites this paper
• Escitalopram in clinical practice in Greece: treatment response and tolerability in depressed patients.

  2009cites this paper
• Escitalopram in clinical practice in Greece: treatment response and tolerability in depressed patients

  2009cites this paper
• Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.

  2009influential citation
• Sensitivity of the Montgomery Asberg Depression Rating Scale to response and its consequences for the assessment of efficacy.

  2009cites this paper
• An analysis of correlations among four outcome scales employed in clinical trials of patients with major depressive disorder

  2009influential citation
• Definitions of response and remission in schizophrenia: recommendations for their use and their presentation

  2009cites this paper
• Sensitivity of the individual items of the Hamilton depression rating scale to response and its consequences for the assessment of efficacy.

  2008cites this paper
• Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis.

  2008cites this paper
• A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder

  2008cites this paper
• Comparative analysis of the sensitivity of the individual items of the Montgomery Asberg depression rating scale to response and its consequences for the assessment of efficacy

  2008cites this paper
• Development of the Bipolar Inventory of Symptoms Scale: concurrent validity, discriminant validity and retest reliability

  2008cites this paper
• Paroxetine for prevention of depressive symptoms induced by interferon‐alpha and ribavirin for hepatitis C

  2007cites this paper
• Antidepressant Dose Reduction and the Risk of Relapse in Major Depressive Disorder

  2007cites this paper
• Depression rating scales in Parkinson's disease: Critique and recommendations

  2007cites this paper
• A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorder.

  2007cites this paper
• The Assessment of Poststroke Depression

  2007cites this paper
• Aphasia in acute stroke

  2007cites this paper
• To What Extent Do the PANSS and CGI-S Overlap?

  2006cites this paper
• The Relative Sensitivity of the Clinical Global Impressions Scale and the Brief Psychiatric Rating Scale in Antipsychotic Drug Trials

  2006cites this paper
• A Comparative Meta-Analysis of Clinical Global Impressions Change in Antidepressant Trials

  2006cites this paper
• A Metaanalysis of Clinical Trials Comparing Moclobemide with Selective Serotonin Reuptake Inhibitors for the Treatment of Major Depressive Disorder

  2006cites this paper
• Duloxetine 60 mg once daily in the treatment of milder major depressive disorder

  2006cites this paper
• A Meta-Analysis of Early Sustained Response Rates Between Antidepressants and Placebo for the Treatment of Major Depressive Disorder

  2006cites this paper
• Sex Differences in Antidepressant Response in Recent Antidepressant Clinical Trials

  2005cites this paper
• Clinical implications of Brief Psychiatric Rating Clinical implications of Brief Psychiatric Rating

  2005cites this paper
• Clinical implications of Brief Psychiatric Rating Scale scores.

  2005cites this paper
• What does the PANSS mean?

  2005cites this paper
• Current awareness in human psychopharmacology

  2004cites this paper
• Scale matters: the need for a Bipolar Depression Rating Scale (BDRS)

  2004cites this paper
• Chapter 11 To fail or not to fail-clinical trials in depression : Summary , discussion and perspectives

  year unknowncites this paper